Search results
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 3 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 4 days agoYesafili is a trademark of Biosimilars Newco, a Biocon Biologics company. Opuviz is a trademark of...
Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration
Journal of the American Medical Association· 2 days agoThis secondary analysis of the ASPREE randomized clinical trial, was conducted to evaluate the effect of long-term low-dose aspirin on age-related macular degeneration.
1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 19 hours agoSo by any standard, if these projections work out, Ocugen is severely undervalued. And that's...
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Investing.com· 4 days agoBiocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....
WTRF Wheeling· 4 days agoBiocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration ...
Astaxanthin Is the Deep Sea Supplement Experts Say Improves Longevity + Benefits Heart and Vision
First for Women via Yahoo News· 4 days agoIf you’d prefer a naturally-sourced supplement (which Dr. Shimek recommends), try Micro Ingredients...
6 Everyday Habits That You Didn't Know Are Ruining Your Vision
CNET· 4 days agoIf you've never experienced any issues with your vision or your eye health for that matter, then you...
FDA approves 2 Eylea biosimilars
Becker’s Hospital Review· 5 days agoThe FDA granted approval to Biocon Biologics' drug Yesafili and Samsung Bioepis and Biogen's drug Opuviz, the agency announced May 20. The two drugs are biosimilars for Eylea, an injection made ...
Daily Low-Dose Aspirin Fails to Prevent AMD in Older Adults
MedPage Today· 2 days agoUse of daily low-dose aspirin for 3 years didn't prevent age-related macular degeneration (AMD) in...